The study will be a pilot randomized control trial with a 1:1 patient randomization of vancomycin powder placement at the time of surgery (compared to no vancomycin placement) with the goal of reducing postoperative complications in patients undergoing an inguinal lymph node dissection for vulvar cancer. The primary objective is to measure the composite rate of postoperative complications within 30 days of inguinal lymph node dissection in patients with vulvar cancer.
1 Primary · 2 Secondary · Reporting Duration: Within 30 days after surgery
30 Total Participants · 2 Treatment Groups
Primary Treatment: Vancomycin powder · No Placebo Group · Phase 2 & 3
Age 18+ · Female Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: